These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 9576945)

  • 1. Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Valpha14 NKT cells.
    Kawano T; Cui J; Koezuka Y; Toura I; Kaneko Y; Sato H; Kondo E; Harada M; Koseki H; Nakayama T; Tanaka Y; Taniguchi M
    Proc Natl Acad Sci U S A; 1998 May; 95(10):5690-3. PubMed ID: 9576945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of decidual Valpha14 NKT cells in abortion.
    Ito K; Karasawa M; Kawano T; Akasaka T; Koseki H; Akutsu Y; Kondo E; Sekiya S; Sekikawa K; Harada M; Yamashita M; Nakayama T; Taniguchi M
    Proc Natl Acad Sci U S A; 2000 Jan; 97(2):740-4. PubMed ID: 10639149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human invariant valpha24+ natural killer T cells activated by alpha-galactosylceramide (KRN7000) have cytotoxic anti-tumour activity through mechanisms distinct from T cells and natural killer cells.
    Nicol A; Nieda M; Koezuka Y; Porcelli S; Suzuki K; Tadokoro K; Durrant S; Juji T
    Immunology; 2000 Feb; 99(2):229-34. PubMed ID: 10692041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DOCK2 is required in T cell precursors for development of Valpha14 NK T cells.
    Kunisaki Y; Tanaka Y; Sanui T; Inayoshi A; Noda M; Nakayama T; Harada M; Taniguchi M; Sasazuki T; Fukui Y
    J Immunol; 2006 Apr; 176(8):4640-5. PubMed ID: 16585555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors.
    Cui J; Shin T; Kawano T; Sato H; Kondo E; Toura I; Kaneko Y; Koseki H; Kanno M; Taniguchi M
    Science; 1997 Nov; 278(5343):1623-6. PubMed ID: 9374462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical contribution of IFN-gamma and NK cells, but not perforin-mediated cytotoxicity, to anti-metastatic effect of alpha-galactosylceramide.
    Hayakawa Y; Takeda K; Yagita H; Kakuta S; Iwakura Y; Van Kaer L; Saiki I; Okumura K
    Eur J Immunol; 2001 Jun; 31(6):1720-7. PubMed ID: 11385616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential production of interferon-gamma by NK1.1(+) T cells and natural killer cells is essential for the antimetastatic effect of alpha-galactosylceramide.
    Smyth MJ; Crowe NY; Pellicci DG; Kyparissoudis K; Kelly JM; Takeda K; Yagita H; Godfrey DI
    Blood; 2002 Feb; 99(4):1259-66. PubMed ID: 11830474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of the antimetastatic effect in the liver and of the hepatocyte injury induced by alpha-galactosylceramide in mice.
    Nakagawa R; Nagafune I; Tazunoki Y; Ehara H; Tomura H; Iijima R; Motoki K; Kamishohara M; Seki S
    J Immunol; 2001 Jun; 166(11):6578-84. PubMed ID: 11359810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of the synthetic ligand-mediated function of liver NK1.1Ag+ T cells in mice by interleukin-12 pretreatment.
    Habu Y; Uchida T; Inui T; Nakashima H; Fukasawa M; Seki S
    Immunology; 2004 Sep; 113(1):35-43. PubMed ID: 15312134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Valpha14 NKT cell-mediated anti-tumor responses and their clinical application.
    Seino K; Fujii S; Harada M; Motohashi S; Nakayama T; Fujisawa T; Taniguchi M
    Springer Semin Immunopathol; 2005 Jun; 27(1):65-74. PubMed ID: 15650847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissociation of NKT stimulation, cytokine induction, and NK activation in vivo by the use of distinct TCR-binding ceramides.
    Ortaldo JR; Young HA; Winkler-Pickett RT; Bere EW; Murphy WJ; Wiltrout RH
    J Immunol; 2004 Jan; 172(2):943-53. PubMed ID: 14707067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulation of the invariant Valpha14 antigen receptor in NKT cells upon activation.
    Harada M; Seino K; Wakao H; Sakata S; Ishizuka Y; Ito T; Kojo S; Nakayama T; Taniguchi M
    Int Immunol; 2004 Feb; 16(2):241-7. PubMed ID: 14734609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutting edge: influence of the TCR V beta domain on the avidity of CD1d:alpha-galactosylceramide binding by invariant V alpha 14 NKT cells.
    Schümann J; Voyle RB; Wei BY; MacDonald HR
    J Immunol; 2003 Jun; 170(12):5815-9. PubMed ID: 12794105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The characteristics of human NKT cells in lung cancer--CD1d independent cytotoxicity against lung cancer cells by NKT cells and decreased human NKT cell response in lung cancer patients.
    Konishi J; Yamazaki K; Yokouchi H; Shinagawa N; Iwabuchi K; Nishimura M
    Hum Immunol; 2004 Nov; 65(11):1377-88. PubMed ID: 15556688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel function of Valpha14+CD4+NKT cells: stimulation of IL-12 production by antigen-presenting cells in the innate immune system.
    Tomura M; Yu WG; Ahn HJ; Yamashita M; Yang YF; Ono S; Hamaoka T; Kawano T; Taniguchi M; Koezuka Y; Fujiwara H
    J Immunol; 1999 Jul; 163(1):93-101. PubMed ID: 10384104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Augmentation of Valpha14 NKT cell-mediated cytotoxicity by interleukin 4 in an autocrine mechanism resulting in the development of concanavalin A-induced hepatitis.
    Kaneko Y; Harada M; Kawano T; Yamashita M; Shibata Y; Gejyo F; Nakayama T; Taniguchi M
    J Exp Med; 2000 Jan; 191(1):105-14. PubMed ID: 10620609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides.
    Kawano T; Cui J; Koezuka Y; Toura I; Kaneko Y; Motoki K; Ueno H; Nakagawa R; Sato H; Kondo E; Koseki H; Taniguchi M
    Science; 1997 Nov; 278(5343):1626-9. PubMed ID: 9374463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of tumor metastasis by adoptive transfer of IL-12-activated Valpha14 NKT cells.
    Shin T; Nakayama T; Akutsu Y; Motohashi S; Shibata Y; Harada M; Kamada N; Shimizu C; Shimizu E; Saito T; Ochiai T; Taniguchi M
    Int J Cancer; 2001 Feb; 91(4):523-8. PubMed ID: 11251976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NKT cells act as regulatory cells rather than killer cells during activation of NK cell-mediated cytotoxicity by alpha-galactosylceramide in vivo.
    Chamoto K; Takeshima T; Kosaka A; Tsuji T; Matsuzaki J; Togashi Y; Ikeda H; Nishimura T
    Immunol Lett; 2004 Aug; 95(1):5-11. PubMed ID: 15325792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutting edge: inhibition of experimental tumor metastasis by dendritic cells pulsed with alpha-galactosylceramide.
    Toura I; Kawano T; Akutsu Y; Nakayama T; Ochiai T; Taniguchi M
    J Immunol; 1999 Sep; 163(5):2387-91. PubMed ID: 10452972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.